Tin tức & Cập nhật

For patients undergoing coronary angioplasty for in-stent restenosis, a paclitaxel-coated balloon significantly lowers the incidence of target lesion failure compared with an uncoated balloon, according to the results of the multicentre AGENT IDE trial.

Treatment with zoledronate leads to reduced fracture rates, with the protective benefit persisting for 1.5 to 3.5 years after the final dose, as reported in the extension phase of a study.

Ruxolitinib cream, a topically administered selective Janus kinase 1/2 inhibitor, appears to be effective for mild-to-moderate atopic dermatitis (AD) in children aged 2–11 years, according to the TRuE-AD3 trial presented at AAAAI 2024.

Benralizumab compares favourably with mepolizumab for inducing remission in adult patients with relapsing or refractory eosinophilic granulomatosis with polyangiitis (EGPA), as shown in the results of the head-to-head phase III MANDARA trial.

The risk of major bleeding and thromboembolic events is low for patients with atrial fibrillation (AF) taking amiodarone with either apixaban or warfarin, with no significant difference between the two anticoagulants, according to a retrospective observational study.

Babies born to mothers who were vaccinated against COVID-19 during pregnancy are not at risk of developmental delays, according to a study.

Treatment with the Fc–FGF21 analogue efruxifermin is well tolerated and appears to further improve liver health in patients with type 2 diabetes (T2D) and metabolic dysfunction-associated steatohepatitis (MASH) with fibrosis who are already on a GLP-1RA, according to a phase IIb trial.